Literature DB >> 9888141

[Clinical value of positron emission tomography in neuromedicine. Position paper on results of an interdisciplinary consensus conference].

T Kuwert1, P Bartenstein, F Grünwald, K Herholz, R Larisch, O Sabri, H J Biersack, E Moser, H W Müller-Gärtner, O Schober, M Schwaiger, U Büll, W D Heiss.   

Abstract

To date, positron emission tomography (PET) is the most powerful method for the in-vivo investigation of human brain metabolism. Besides extensive application of this technology in the neurosciences, PET is also being increasingly used as a clinical tool. However, despite its acceptance in clinical practice a major obstacle is its high costs. The present article reviews the literature on the clinical use of PET in neurology, neurosurgery, and psychiatry in order to substantiate the clinical indications for PET in these specialties as established by an interdisciplinary conference.

Entities:  

Mesh:

Year:  1998        PMID: 9888141     DOI: 10.1007/s001150050382

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  5 in total

1.  [Principles of PET/CT and clinical application].

Authors:  A Bockisch; T Beyer; G Antoch; P Veit; S Müller; R Pink; S Rosenbaum; H Kühl
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

2.  EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.

Authors:  Andrea Varrone; Susanne Asenbaum; Thierry Vander Borght; Jan Booij; Flavio Nobili; Kjell Någren; Jacques Darcourt; Ozlem L Kapucu; Klaus Tatsch; Peter Bartenstein; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

Review 3.  PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan.

Authors:  Tomohiro Kaneta
Journal:  Jpn J Radiol       Date:  2020-02-10       Impact factor: 2.374

Review 4.  [Neurobiological early diagnosis of Alzheimer's disease].

Authors:  H Hampel; S J Teipel; K Bürger
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

Review 5.  Biological markers for early detection and pharmacological treatment of Alzheimer's disease.

Authors:  Harald Hampel; Karl Broich; Yvonne Hoessler; Johannes Pantel
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.